ea0037ep742 | Pituitary: clinical | ECE2015
van Varsseveld Nadege
, van Bunderen Christa
, Franken Anton
, Koppeschaar Hans
, van der Lely Aart Jan
, Drent Madeleine
Objective: Growth hormone treatment (GHT) is a widely accepted treatment in growth hormone deficient (GHD) adults with nonfunctioning pituitary adenoma (NFPAs). However, concerns remain about the safety of GHT, because of its potentially stimulating effect on tumour (re)growth. The aim of this study was to evaluate tumour progression in NFPA patients using GHT.Patients and methods: From the Dutch National Registry of growth hormone treatment in adults, a...